Astrid M Botty Van den Bruele (Astrid Botty van den Bruele)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Affordable Care Act

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Annals of surgical oncology

The breast journal

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah E Woriax, Samantha M Thomas, Jennifer K Plichta, Oluwadamilola M Fayanju, Astrid M Botty Van den Bruele, Akiko Chiba, E Shelley Hwang, Maggie L DiNome
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Hannah E Woriax, Samantha M Thomas, Jennifer K Plichta, Oluwadamilola M Fayanju, Astrid M Botty Van den Bruele, Akiko Chiba, E Shelley Hwang, Maggie L DiNome
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Astrid M Botty Van den Bruele, Anna Weiss, null null
Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer. Annals of surgical oncology (2024)
Astrid M Botty Van den Bruele, Anna Weiss, null null
Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer. Annals of surgical oncology 31 (9) (2024)
Hannah E Woriax, Samantha M Thomas, Jennifer K Plichta, Oluwadamilola M Fayanju, Astrid M Botty Van den Bruele, Akiko Chiba, E Shelley Hwang, Maggie L DiNome
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Astrid M Botty Van den Bruele, Anna Weiss, null null
Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer. Annals of surgical oncology 31 (9) (2024)
Hannah E Woriax, Samantha M Thomas, Jennifer K Plichta, Oluwadamilola M Fayanju, Astrid M Botty Van den Bruele, Akiko Chiba, E Shelley Hwang, Maggie L DiNome
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hannah E Woriax, Samantha M Thomas, Jennifer K Plichta, Oluwadamilola M Fayanju, Astrid M Botty Van den Bruele, Akiko Chiba, E Shelley Hwang, Maggie L DiNome
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Astrid M Botty Van den Bruele, Marie Crandall, David Chesire, Scott Sylvester, John Murray
Breast lidocaine priming for improved mastectomy survival. The breast journal 26 (10) (2020)